期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Hepatoxicity associated with weight-loss supplements: A case for better post-marketing surveillance 被引量:3
1
作者 Ano Lobb 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第14期1786-1787,共2页
There is a growing number of case reports of hepatoxicity from the widely marketed weight-loss supplement Hydroxycut, which contains the botanical ingredient Garcinia cambogia . These case reports may substantially un... There is a growing number of case reports of hepatoxicity from the widely marketed weight-loss supplement Hydroxycut, which contains the botanical ingredient Garcinia cambogia . These case reports may substantially undercount the true magnitude of harm. Based on the past experience with harmful dietary supplements, US regulators should assume the more precautionary approach favored by Canada and Europe. Lacking effective adverse event surveillance for supplements, or the requirements to prove safety prior to coming to the market, case reports such as those summarized here assume added importance. 展开更多
关键词 Hydroxycut Dietary supplements Garciniacambogia Liver failure Weight loss Super citrimax Hca-sx
暂未订购
No evidence demonstrating hepatotoxicity associated with hydroxycitric acid 被引量:2
2
作者 Sidney J Stohs Harry G Preuss +4 位作者 Sunny E Ohia Gilbert R Kaats Carl L Keen Lonnie D Williams George A Burdock 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第32期4087-4089,共3页
Although a number of cases of hepatotoxicity are associated with the use of Hydroxycut weight management products, it has been alleged that their effects are primarily due to the presence of hydroxycitric acid (HCA, a... Although a number of cases of hepatotoxicity are associated with the use of Hydroxycut weight management products, it has been alleged that their effects are primarily due to the presence of hydroxycitric acid (HCA, as Super CitriMax) in the formulations. However, while these products contain up to 20 different ingredients, some do not contain HCA. Case studies reported to date have not considered in depth the literature on the numerous animal and human studies that have been conducted on the safety and effi cacy of HCA. No HCA-associated hepatotoxicity or treatment-related adverse effects have been reported in these studies, and thus it is premature to make the assumptions presented in the recent case studies regarding Hydroxycut. If it is established in well controlled studies that the use of these formulations with and/or without HCA can result in the occurrence or progression of hepatotoxicity, additional studies should be conducted to characterize the causative factor(s). 展开更多
关键词 Hydroxycitric acid Super citrimax Hydroxycitric acid-SX Garcinia cambogia Hydroxycut Liver failure HEPATOTOXICITY Safety and efficacy
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部